MONTREAL, June 20, 2022 /PRNewswire/ - Aifred Health, an award-winning digital healthcare company, today announced the treatment of the first patient in its 350 patient North American Clinical Trial. This
Aifred Health Named Top 3 Finalist in Global IBM Watson AI XPRIZE Competition
News provided by
Share this article
Share this article
MONTREAL, Feb. 16, 2021 /PRNewswire/ - Aifred Health announced today that the XPRIZE jury has selected Aifred Health as one of the 3 finalists for the IBM Watson AI XPRIZE. The company is competing for the grand prize of US$3.0 million which will be awarded in June, 2021, with 2nd and 3rd prize winners receiving US$1.0 million and US$0.5 million respectively.
Montreal-based Aifred Health was one of more than 700 applicants for this XPRIZE focused on employing AI to solve the world s grand challenges. Teams were judged by world-leading experts in AI who conducted extensive due diligence and reviews of each team s application and their ability to meet the key criteria of achieved technical impact; evidenced real-world impact; scalability of real-world impact; and ethics and safety.